Attention Celerion eReg Portal Users:
We are experiencing technical issues with our eReg portal for mobile device users. Please login to the eReg portal using a desktop device to view study opportunities and details in your profile. Thank you for your patience and understanding.

 
 
 
 

CA49978-1A - 0x0000000000006A31

Males & Females of Non-Childbearing Potential

Marlin

* Stipend may pay up to reflected amount.
Start Date: 
February 5, 2026 - 3:30pm
End Date: 
May 29, 2026 - 11:00am

Study Details

Study Number: CA49978
Group Number: 1A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $9,000.00

Study Criteria

Age: 19 - 55
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat inflammatory bowel disease (IBD) and rheumatoid arthritis (RA).
Route of Administration: Injection IV infusion; Injection subcutaneous
Blood Draws: 16

Study Schedule

Schedule Type: Short stays with returns
Study Length: One - 5 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Monday 1/26/2026
Monday 1/26/2026
Monday 1/26/2026
Thursday 1/29/2026
Thursday 1/29/2026
Thursday 1/29/2026
Tuesday 2/3/2026
Tuesday 2/3/2026
Tuesday 2/3/2026

Doctor Exam Dates:

Event Day Event Date
Monday 1/26/2026
Thursday 1/29/2026
Tuesday 2/3/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 2/5/2026 3:30:00 PM Tuesday 2/10/2026 10:30:00 AM 1 Lincoln
Return Friday 2/20/2026 8:50:00 AM Friday 2/20/2026 10:00:00 AM 1 Lincoln
Return Friday 3/6/2026 8:50:00 AM Friday 3/6/2026 10:00:00 AM 1 Lincoln
Return Friday 4/3/2026 9:50:00 AM Friday 4/3/2026 11:00:00 AM 1 Lincoln
Return Friday 5/1/2026 9:50:00 AM Friday 5/1/2026 11:00:00 AM 1 Lincoln
Return Friday 5/29/2026 9:50:00 AM Friday 5/29/2026 11:00:00 AM 1 Lincoln